EUVIMEDEUVIMED entdecken
ValidierungsstudieFall-Kontroll-Studie

Development and validation of a novel nomogram for predicting good neoangiogenesis after encephaloduroarteriosynangiosis in patients with moyamoya disease and type 2 diabetes mellitus: a case-control study

Jing-Jie Li, Bin Ren, Xiao-Peng Wang, Qian-Nan Wang, Xiang-Yang Bao, Qing-Bao Guo, Zi-Qing Kong, Jia-Qi Liu, Gan Gao, Min-Jie Wang, Si-Meng Liu, He-Guan Fu und 2 weitere

Journal of Neurosurgery · 2024

DOI: 10.3171/2024.2.jns24208 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Neurosurgery, 2024. Verfasst von Jing-Jie Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: 1Medical School of Chinese PLA, Beijing. Hauptthemen laut MEDLINE: Moyamoya Disease, Diabetes Mellitus, Type 2, Nomograms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Diabetes is often linked to poorer outcomes in patients with moyamoya disease (MMD). However, experience has shown that certain individuals with diabetes have favorable outcomes after encephaloduroarteriosynangiosis (EDAS). The authors aimed to develop a nomogram to predict good neoangiogenesis in patients with MMD and type 2 diabetes mellitus (T2DM) to aid neurosurgeons in the identification of suitable candidates for EDAS. METHODS Adults with MMD and T2DM who underwent EDAS between June 2004 and December 2018 were included in the analysis. In total, 126 patients (213 hemispheres) with MMD and T2DM from the Fifth Medical Centre of the Chinese PLA General Hospital were included and randomly divided into training (152 hemispheres) and internal validation (61 hemispheres) cohorts at a ratio of 7:3. Univariate logistic and least absolute shrinkage and selection operator regression analyses were used to identify the significant factors associated with good neoangiogenesis, which were used to develop a nomogram. The discrimination, calibration, and clinical utility were assessed. RESULTS A total of 213 hemispheres in 126 patients were reviewed, including 152 (71.36%) hemispheres with good postoperative collateral formation and 61 (28.64%) with poor postoperative collateral formation. The authors selected 4 predictors (FGD5 rs11128722, VEGFA rs9472135, Suzuki stage, and internal carotid artery [ICA] moyamoya vessels) for nomogram development. The C-indices of the nomogram in the training and internal validation cohorts were 0.873 and 0.841, respectively. The nomogram exhibited a sensitivity of 84.5% and specificity of 81.0%. The positive and negative predictive values were 92.1% and 66.7%, respectively. The calibration curves indicated high predictive accuracy, and receiver operating characteristic curve analysis showed the superiority of the nomogram. The decision-making analysis validated the fitness and clinical application value of this nomogram. Then a web-based calculator to facilitate clinical application was generated. CONCLUSIONS The nomogram developed in this study accurately predicted neoangiogenesis in patients with MMD and T2DM after EDAS and may assist neurosurgeons in identifying suitable candidates for indirect revascularization surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Moyamoya DiseaseDiabetes Mellitus, Type 2NomogramsHumansMaleFemaleMiddle AgedAdultCase-Control StudiesCerebral RevascularizationTreatment OutcomeNeovascularization, PhysiologicRetrospective Studies

Stichwörter der Autor:innen

encephaloduroarteriosynangiosismoyamoya diseaseneoangiogenesisnomogramtype 2 diabetes mellitusvascular disorders

Autor:innen und Institutionen

  • 1Medical School of Chinese PLA, Beijing.
  • Departments of2Neurosurgery and.
  • 3Department of Neurosurgery, Eighth Medical Centre, Chinese PLA General Hospital, Beijing, China.
  • 4Neurology, First Medical Centre, Chinese PLA General Hospital, Beijing; and.

Zitieren

APA

Li, J. J., Ren, B., Wang, X. P., Wang, Q. N., Bao, X. Y., Guo, Q. B., Kong, Z. Q., Liu, J. Q., Gao, G., Wang, M. J., Liu, S. M., Fu, H. G., Tong, H. Y., & Duan, L. (2024). Development and validation of a novel nomogram for predicting good neoangiogenesis after encephaloduroarteriosynangiosis in patients with moyamoya disease and type 2 diabetes mellitus: a case-control study. Journal of Neurosurgery. https://doi.org/10.3171/2024.2.jns24208

Vancouver

Li JJ, Ren B, Wang XP, Wang QN, Bao XY, Guo QB, et al. Development and validation of a novel nomogram for predicting good neoangiogenesis after encephaloduroarteriosynangiosis in patients with moyamoya disease and type 2 diabetes mellitus: a case-control study. Journal of Neurosurgery. 2024. doi:10.3171/2024.2.jns24208

BibTeX
@article{Li2024,
  author = {Li, Jing-Jie and Ren, Bin and Wang, Xiao-Peng and Wang, Qian-Nan and Bao, Xiang-Yang and Guo, Qing-Bao and Kong, Zi-Qing and Liu, Jia-Qi and Gao, Gan and Wang, Min-Jie and Liu, Si-Meng and Fu, He-Guan and Tong, Huai-Yu and Duan, Lian},
  title = {Development and validation of a novel nomogram for predicting good neoangiogenesis after encephaloduroarteriosynangiosis in patients with moyamoya disease and type 2 diabetes mellitus: a case-control study},
  journal = {Journal of Neurosurgery},
  year = {2024},
  doi = {10.3171/2024.2.jns24208}
}
Kostenlos starten →